- Home
- CCD vs IRMD Comparison
CCD vs IRMD Comparison
Compare CCD & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCD
- IRMD
- Stock Information
- Founded
- CCD 2014
- IRMD 1992
- Country
- CCD United States
- IRMD United States
- Employees
- CCD N/A
- IRMD N/A
- Industry
- CCD Trusts Except Educational Religious and Charitable
- IRMD Medical/Dental Instruments
- Sector
- CCD Finance
- IRMD Health Care
- Exchange
- CCD Nasdaq
- IRMD Nasdaq
- Market Cap
- CCD 656.6M
- IRMD 662.5M
- IPO Year
- CCD N/A
- IRMD 2014
- Fundamental
- Price
- CCD $21.97
- IRMD $51.86
- Analyst Decision
- CCD
- IRMD Strong Buy
- Analyst Count
- CCD 0
- IRMD 1
- Target Price
- CCD N/A
- IRMD $72.00
- AVG Volume (30 Days)
- CCD 96.1K
- IRMD 34.0K
- Earning Date
- CCD 01-01-0001
- IRMD 05-05-2025
- Dividend Yield
- CCD 10.61%
- IRMD 1.30%
- EPS Growth
- CCD N/A
- IRMD 10.72
- EPS
- CCD N/A
- IRMD 1.55
- Revenue
- CCD N/A
- IRMD $75,154,639.00
- Revenue This Year
- CCD N/A
- IRMD $10.58
- Revenue Next Year
- CCD N/A
- IRMD $17.74
- P/E Ratio
- CCD N/A
- IRMD $33.82
- Revenue Growth
- CCD N/A
- IRMD 11.04
- 52 Week Low
- CCD $16.93
- IRMD $41.60
- 52 Week High
- CCD $24.68
- IRMD $63.29
- Technical
- Relative Strength Index (RSI)
- CCD 60.84
- IRMD 47.80
- Support Level
- CCD $21.66
- IRMD $50.31
- Resistance Level
- CCD $22.35
- IRMD $53.88
- Average True Range (ATR)
- CCD 0.33
- IRMD 1.84
- MACD
- CCD 0.14
- IRMD -0.04
- Stochastic Oscillator
- CCD 82.25
- IRMD 44.93
About CCD Calamos Dynamic Convertible & Income Fund
Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.